Press release
Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics, ENA Respiratory Pty Ltd, Codagenix, AlloVir, Osivax, CureVac AG
DelveInsight's, "Influenza Pipeline Insight 2024" report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in Influenza pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.Discover the latest drugs and treatment options in the Influenza Pipeline. Dive into DelveInsight's comprehensive report today! @ Influenza Pipeline Outlook [https://www.delveinsight.com/sample-request/influenza-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Influenza Pipeline Report
* August 2024:- Hoffmann-La Roche- A Phase IIIb Multicenter, Single-Arm, Open-Label Surveillance Study of Susceptibility to Baloxavir Marboxil in Patients With Influenza. The purpose of this study is to evaluate the pre-treatment and single-dose post treatment susceptibility of baloxavir marboxil in participants aged 1 to
* August 2024:- Janssen Vaccines & Prevention B.V.- A Randomized, Double-blind, Placebo-controlled, First-in-human Phase 1/2a Study to Evaluate Safety, Reactogenicity and Immunogenicity of a Universal Influenza (Uniflu) Vaccine With INFLUENZA G1 mHA in Healthy Adults. The primary purpose of this study is to evaluate safety/ reactogenicity of INFLUENZA G1 mini-hemagglutinin stem-derived protein vaccine antigen (mHA), with or without Al(OH)3 adjuvant, in healthy adults greater than or equal to (>=) 18 to less than or equal to (
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics, ENA Respiratory Pty Ltd, Codagenix, AlloVir, Osivax, CureVac AG here
News-ID: 3635365 • Views: …
More Releases from ABNewswire

CopperJoint Debuts New Colorways of CopperJoint Compression Socks with Pinstripe …
From the boardroom to the break room, the new CopperJoint compression socks for men and women feature subtle pinstripes in black, white, blue, and black & tan. Designed to pair with slacks, scrubs, or uniforms, the socks offer odor resistance, moisture-wicking comfort, and 15-20 mmHg graduated compression for daily wellness. "We're taking compression out of the clinic and into your daily wardrobe," said a spokesperson.
NASHVILLE, TN - September 20, 2025…

Best Deals on Christian Nodal Concert Tickets 2025 - Instant Savings with Promo …
Catch Christian Nodal live in 2025! Discover the best deals on concert tickets and enjoy instant savings using promo code CITY10 at CapitalCityTickets.com. Don't miss your chance to see his unforgettable performances while saving big online.
Christian Nodal, the mariachi prodigy from Sonora, Mexico, is bringing his soulful voice and heartfelt rancheras to U.S. stages with the highly anticipated PA'L CORA TOUR in 2025. Born in 1999, Nodal exploded onto the…

Industry Analysis: Advanced Marketing Automation and AI Integration Strategies D …
Tony Hayes releases technical analysis of 20 advanced marketing automation and AI integration strategies delivering exceptional performance metrics. Report covers Reddit SEO exploitation, YouTube algorithm optimization, ChatGPT API integrations, and Facebook's new campaign architecture for marketing professionals.
September 19, 2025 - Marketing technology strategist Tony Hayes has published an in-depth industry analysis examining 20 advanced automation strategies and AI integration methods currently delivering exceptional performance metrics for digital marketing professionals and…

Alex Villas Group - among Bali's Top5 developers
Image: https://www.abnewswire.com/upload/2025/09/3713bc3a8def54e1edb0ecadf13cdc5c.jpg
Bali, Indonesia - Alex Villas Group, an international developer and investment holding, proudly reaffirms its position as one of Bali's topfive real estate developers. This reputation is built on impressive performance, the scale of delivered projects, and a unique approach to working with investors.
Market data and client feedback highlight the key advantages that set Alex Villas Group apart:
*
Unprecedented experience and scale. With a portfolio including more than 23,000 m…
More Releases for Influenza
Multivalent Influenza Vaccines Market Advancing Influenza Prevention Strategies …
The "Multivalent Influenza Vaccines Market" research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Multivalent Influenza Vaccines industry along with various other factors over the predicted period 2024-2030. The report on the Multivalent Influenza Vaccines market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels, profit margin, etc.…
Influenza Diagnostics Market - Rapid Detection, Effective Protection: Influenza …
Newark, New Castle, USA: The "Influenza Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Influenza Diagnostics Market: https://www.growthplusreports.com/report/influenza-diagnostics-market/8780
This latest report researches the industry structure, sales, revenue,…
Influenza Medication Market - Fight off the influenza virus with effective and r …
Newark, New Castle, USA: The "Influenza Medication Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Influenza Medication Market: https://www.growthplusreports.com/report/influenza-medication-market/7859
This latest report researches the industry structure, sales, revenue,…
Influenza Medication Market - Revolutionizing Flu Treatment: Innovating Advanced …
Newark, New Castle, USA - new report, titled Influenza Medication Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Medication market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Medication market. The report offers an overview of the market, which…
Influenza Vaccines Market - Empowering Strength, Nurturing Immunity: Innovating …
Newark, New Castle, USA - new report, titled Influenza Vaccines Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Vaccines market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Vaccines market. The report offers an overview of the market, which…
H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,…